Peering Into Alnylam Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Alnylam Pharmaceuticals (NYSE:ALNY) has seen a 72.68% increase in its short percent of float, now at 3.35% of all regular shares available for trading. This indicates a rise in bearish sentiment among investors. However, its short interest is still lower than the peer group average of 6.83%.
July 17, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Alnylam Pharmaceuticals has experienced a significant increase in short interest, rising by 72.68% to 3.35% of its float. This suggests growing bearish sentiment among investors, although its short interest remains below the peer group average of 6.83%.
The significant increase in short interest indicates that more investors are betting against the stock, which could lead to downward pressure on the stock price in the short term. However, the short interest is still below the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100